BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3711193)

  • 1. Design of fluorescent probes for an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Al-Ahmad RK
    J Chromatogr; 1986 Apr; 376():211-9. PubMed ID: 3711193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Application to the location of cells possessing this enzyme.
    Steven FS; Griffin MM; Al-Ahmad RK
    Eur J Biochem; 1985 May; 149(1):35-40. PubMed ID: 2581779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells.
    Steven FS; Griffin MM; Freemont AJ; Johnson J
    J Enzyme Inhib; 1988; 2(2):117-27. PubMed ID: 3236068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further inhibition studies on guanidinobenzoatase, a trypsin-like enzyme associated with tumour cells.
    Steven FS; Griffin MM; Wong TL; Yasmin R; Mangel WF
    J Enzyme Inhib; 1987; 1(3):187-201. PubMed ID: 3334244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of guanidinobenzoatase by a substrate for trypsin-like enzymes.
    Steven FS; Griffin MM; Mangel WF; Maier H; Altmannsberger M
    J Enzyme Inhib; 1988; 2(3):209-14. PubMed ID: 2467971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections.
    Steven FS; Griffin MM; Maier H; Weidauer H; Mangel WF; Altmannsberger M
    Br J Cancer; 1988 Jul; 58(1):57-60. PubMed ID: 3166893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of guanidinobenzoatase and their possible role in cell migration.
    Steven FS; Griffin MM
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():137-43. PubMed ID: 3202961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent inhibitors of a cell surface protease used to locate leukaemia cells in kidney sections.
    Steven FS; Griffin MM; Wong TL; Jackson H; Barnett F
    J Enzyme Inhib; 1987; 1(3):203-13. PubMed ID: 3334245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Wong TL; Itzhaki S
    J Enzyme Inhib; 1986; 1(2):127-37. PubMed ID: 3508910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the functional similarity between tumour cell surface guanidinobenzoatase and tissue type plasminogen activator.
    Steven FS; Griffin MM; Cederholm-Williams SA; Mangel WF; Maier H
    Anticancer Res; 1991; 11(2):641-7. PubMed ID: 1905903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent location of human colonic tumour cells by means of an enzyme-inhibitor complex.
    Steven FS; Maier H; Talbot IC
    J Enzyme Inhib; 1990; 3(3):229-36. PubMed ID: 2079640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitor reacting with a tumour cell surface protease can be exchanged with plasminogen activator inhibitor (PAI-1).
    Steven FS; Booth NA
    J Enzyme Inhib; 1991; 4(3):273-9. PubMed ID: 2037870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the proteolytic enzyme guanidinobenzoatase in human basal cell carcinoma.
    Steven FS; Maier H; Born A; Weidauer H
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(6):360-4. PubMed ID: 2480560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of a protease associated with tumour cells and the probable mechanism of regulation of this interaction in vivo.
    Steven FS; Maier H; Arndt J
    J Enzyme Inhib; 1989; 3(2):145-57. PubMed ID: 2489235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region.
    Steven FS; Williams LA; Maier H; Arndt J; Weidauer H; Born A
    J Cancer Res Clin Oncol; 1990; 116(1):57-64. PubMed ID: 2312606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and purification of a guanidinobenzoatase: a possible marker of human renal carcinoma.
    Poustis-Delpont C; Descomps R; Auberger P; Delque-Bayer P; Sudaka P; Rossi B
    Cancer Res; 1992 Jul; 52(13):3622-8. PubMed ID: 1617634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for different isoenzymic forms of a cell surface protease, guanidinobenzoatase, associated with tumours.
    Steven FS; Griffin MM; Blakey DC; Talbot IC; Hanski C; Bell J
    Anticancer Res; 1992; 12(6B):2159-64. PubMed ID: 1295463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of the plasminogen activator inhibitor (PAI-1) for the iso enzyme of guanidinobenzoatase on the surface of colonic carcinoma cells.
    Steven FS; Anees M; Booth NA
    Anticancer Res; 1995; 15(1):205-10. PubMed ID: 7733635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.